SEC Comment Letter 0000000000-25-001051 to KALA BIO, Inc. (KALA) (CIK 0001479419) (KALA)
KALA BIO, Inc. (KALA) (CIK 0001479419)
Date: Jan. 31, 2025 · CIK: 0001479419 · Accession: 0000000000-25-001051
AI Filing Summary & Sentiment
File numbers found in text: 333-284480
Letter
January 31, 2025 Mark Iwicki Chief Executive Officer and Chair of Board of Directors KALA BIO, Inc. 1167 Massachusetts Avenue Arlington, MA 02476 Re:KALA BIO, Inc. Registration Statement on Form S-3 Filed January 24, 2025 File No. 333-284480 Dear Mark Iwicki: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Andrea Sorrentino, Esq.
Show Raw Text
January 31, 2025
Mark Iwicki
Chief Executive Officer and Chair of Board of Directors
KALA BIO, Inc.
1167 Massachusetts Avenue
Arlington, MA 02476
Re:KALA BIO, Inc.
Registration Statement on Form S-3
Filed January 24, 2025
File No. 333-284480
Dear Mark Iwicki:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Andrea Sorrentino, Esq.